Use of fine-needle aspiration biopsy and frozen section in the management of the solitary thyroid nodule

Background. This study evaluates the indication for frozen section (FSx) in the management of the solitary thyroid nodule given the increasing use of fine-needle aspiration biopsy (FNAB). Methods. The charts of 561 patients who underwent thyroidectomy for a solitary nodule were reviewed. Each patien...

Full description

Saved in:
Bibliographic Details
Published in:Surgery Vol. 122; no. 6; pp. 1021 - 1027
Main Authors: Sabel, Michael S, Staren, Edgar D, Gianakakis, Louis M, Dwarakanathan, Suri, Prinz, Richard A
Format: Journal Article
Language:English
Published: Mosby, Inc 01-12-1997
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. This study evaluates the indication for frozen section (FSx) in the management of the solitary thyroid nodule given the increasing use of fine-needle aspiration biopsy (FNAB). Methods. The charts of 561 patients who underwent thyroidectomy for a solitary nodule were reviewed. Each patient underwent either FNAB, FSx, or both. Results were compared to the final diagnosis to evaluate their effectiveness in predicting malignancy. Results. The sensitivity and specificity for FNAB alone (162 patients) were 86% and 91%, respectively, and for FSx (494 patients) 79% and 99%, respectively. The routine use of FSx with diagnostic FNABs did not improve the accuracy over either test alone. Sensitivity, specificity, and accuracy were essentially unchanged when the use of FSx was limited to just atypical FNAB but dropped significantly when FSx was not used. Conclusions. When results of FNAB and FSx are interpreted as benign or malignant, both are highly accurate predictors of malignancy. Routine use of FSx and FNAB does not improve the sensitivty or specificity in the detection of malignancy over that of either examination alone. FSx proved useful in determining the extent of operation only when results of the FNAB were atypical.
ISSN:0039-6060
1532-7361
DOI:10.1016/S0039-6060(97)90204-X